Immunotherapy: An Overview
Immunotherapy represents a revolutionary approach in cancer treatment, leveraging the body's immune system to identify and destroy cancer cells with precision.
Checkpoint Inhibitors Breakthrough
Checkpoint inhibitors, a class of drugs, have transformed cancer care by unmasking cancer cells to the immune system, significantly improving patient survival rates in several cancers.
CAR T-cell Therapy
Chimeric Antigen Receptor (CAR) T-cell therapy engineers patients' T-cells to better recognize cancer cells. This personalized approach has shown remarkable success in treating certain blood cancers.
Oncolytic Virus Therapy
Oncolytic viruses selectively infect and lyse cancer cells while sparing normal tissues, simultaneously working with the immune system to enhance its anti-tumor response.
Cancer Vaccines Development
Unlike traditional vaccines, cancer vaccines are designed to train the immune system to attack existing cancer cells. Personalized cancer vaccines are an emerging and promising field.
Bispecific Antibodies Evolution
Bispecific antibodies are engineered to attach to both cancer cells and immune cells, thereby bringing them into close proximity and enhancing the immune system's ability to fight cancer.
Microbiome's Role Uncovered
Research reveals the gut microbiome's significant impact on immunotherapy efficacy. Certain bacteria can improve treatment responses, opening new avenues for combinational therapies.
What does immunotherapy leverage to fight cancer?
Chemicals to destroy tumors
Radiation to target cancer cells
Body's immune system precision
Company